Annual Total Long Term Liabilities
$1.03 B
+$720.79 M+231.53%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual total long term liabilities is $1.03 billion, with the most recent change of +$720.79 million (+231.53%) on December 31, 2023.
- During the last 3 years, IBRX annual total long term liabilities has risen by +$760.37 million (+279.82%).
- IBRX annual total long term liabilities is now at all-time high.
Performance
IBRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.05 B
-$31.82 M-2.95%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly total long term liabilities is $1.05 billion, with the most recent change of -$31.82 million (-2.95%) on September 30, 2024.
- Over the past year, IBRX quarterly long term liabilities has dropped by -$31.82 million (-2.95%).
- IBRX quarterly long term liabilities is now -2.95% below its all-time high of $1.08 billion, reached on June 30, 2024.
Performance
IBRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IBRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +231.5% | -3.0% |
| 3 y3 years | +279.8% | +224.5% |
| 5 y5 years | - | +224.5% |
IBRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +231.5% | -3.0% | +237.8% |
| 5 y | 5-year | at high | +279.8% | -3.0% | +285.6% |
| alltime | all time | at high | +279.8% | -3.0% | +285.6% |
ImmunityBio Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.05 B(-2.9%) |
| Jun 2024 | - | $1.08 B(+4.0%) |
| Mar 2024 | - | $1.04 B(+0.6%) |
| Dec 2023 | $1.03 B(+231.5%) | $1.03 B(+37.1%) |
| Sep 2023 | - | $752.74 M(+133.1%) |
| Jun 2023 | - | $322.93 M(+4.1%) |
| Mar 2023 | - | $310.17 M(-0.4%) |
| Dec 2022 | $311.31 M | $311.31 M(-56.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $711.18 M(+95.6%) |
| Jun 2022 | - | $363.64 M(+5.1%) |
| Mar 2022 | - | $346.13 M(+0.7%) |
| Dec 2021 | $343.83 M(+26.5%) | $343.83 M(+1.4%) |
| Sep 2021 | - | $338.96 M(+2.6%) |
| Jun 2021 | - | $330.46 M(+4.9%) |
| Mar 2021 | - | $314.90 M(+15.9%) |
| Dec 2020 | $271.74 M | $271.74 M |
FAQ
- What is ImmunityBio annual total long term liabilities?
- What is the all time high annual total long term liabilities for ImmunityBio?
- What is ImmunityBio annual total long term liabilities year-on-year change?
- What is ImmunityBio quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ImmunityBio?
- What is ImmunityBio quarterly long term liabilities year-on-year change?
What is ImmunityBio annual total long term liabilities?
The current annual total long term liabilities of IBRX is $1.03 B
What is the all time high annual total long term liabilities for ImmunityBio?
ImmunityBio all-time high annual total long term liabilities is $1.03 B
What is ImmunityBio annual total long term liabilities year-on-year change?
Over the past year, IBRX annual total long term liabilities has changed by +$720.79 M (+231.53%)
What is ImmunityBio quarterly total long term liabilities?
The current quarterly long term liabilities of IBRX is $1.05 B
What is the all time high quarterly long term liabilities for ImmunityBio?
ImmunityBio all-time high quarterly total long term liabilities is $1.08 B
What is ImmunityBio quarterly long term liabilities year-on-year change?
Over the past year, IBRX quarterly total long term liabilities has changed by -$31.82 M (-2.95%)